Emergency neurological life support: Acute ischemic stroke

Neurocritical Care

Volumn 17, Issue SUPPL. 1, 2012, Pages

  Gross, Hartmut ^a   Sung, Gene ^b   Weingart, Scott D ^c   Smith, Wade S ^d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Algorithm; ENLS; Ischemic stroke; Protocol; Tissue plasminogen activator

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ATORVASTATIN; CLOPIDOGREL; GLUCOSE; LABETALOL; NICARDIPINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE PLASMINOGEN ACTIVATOR;

ANGIONEUROTIC EDEMA; ANTICOAGULANT THERAPY; BLOOD CELL COUNT; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EMERGENCY NEUROLOGICAL LIFE SUPPORT; EMERGENCY TREATMENT; GLUCOSE BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTERDISCIPLINARY COMMUNICATION; INTRACRANIAL HYPERTENSION; LABORATORY TEST; LOW RISK POPULATION; MAGNETIC RESONANCE ANGIOGRAPHY; MENTAL DETERIORATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PATIENT REFERRAL; PATIENT TRANSPORT; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; RISK REDUCTION; SCORING SYSTEM; SMOKING CESSATION; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; VITAL SIGN;

ACUTE DISEASE; ALGORITHMS; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; EMERGENCY MEDICAL SERVICES; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84869201199     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9749-2     Document Type: Review

References (8)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18-209.
2. Adams HP Jr., del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-711. (Pubitemid 46691097)
3. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke; a journal of cerebral circulation. 1997;28:2109-18.
4. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr., American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40: 2945-8.
5. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359:1317-29.
6. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40: 2276-93.
7. Cucchiara B, Ross M. Transient ischemic attack: risk stratification and treatment. Ann Emerg Med. 2008;52:S27-39. (Pubitemid 352014869)
8. Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961-9. (Pubitemid 47562312)